These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32554327)

  • 1. The influence of narcolepsy on olfactory function: a review.
    de Martin Truzzi G; Naufel MF; Tufik S; Coelho FM
    Sleep Med; 2020 Aug; 72():75-81. PubMed ID: 32554327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).
    Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D
    Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory dysfunction in narcolepsy with cataplexy.
    Bayard S; Plazzi G; Poli F; Serra L; Ferri R; Dauvilliers Y
    Sleep Med; 2010 Oct; 11(9):876-81. PubMed ID: 20817549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory dysfunction in narcolepsy with and without cataplexy.
    Buskova J; Klaschka J; Sonka K; Nevsimalova S
    Sleep Med; 2010 Jun; 11(6):558-61. PubMed ID: 20513636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
    Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
    Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated heart rate response is associated with hypocretin deficiency in patients with narcolepsy.
    Sorensen GL; Knudsen S; Petersen ER; Kempfner J; Gammeltoft S; Sorensen HB; Jennum P
    Sleep; 2013 Jan; 36(1):91-8. PubMed ID: 23288975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
    Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy.
    Zhang S; Zeitzer JM; Sakurai T; Nishino S; Mignot E
    J Physiol; 2007 Jun; 581(Pt 2):649-63. PubMed ID: 17379635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
    Dauvilliers Y; Jennum P; Plazzi G
    Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.